Skip to main content
Caplight Logo









Cellestial Health

Cellestial Health

Private
CambridgeHealthcare & Life Scienceshttps://cellestialhealth.com/

Last Round

Seed

Dec 2, 2025

Total Funding Raised

$1.18M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cellestial Health is a biopharmaceutical company developing small molecule therapeutics designed to slow the progression of neurodegenerative diseases by targeting astrocytes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysmall-molecule therapeuticsneurodegenerative diseasedrug discoveryastrocytic networksParkinson's diseasecentral nervous systemCNSpreclinical drug developmentbrain-permeable drugsbiotech startupdisease-modifying treatmentdrug pipelinebiopharmatherapeutic research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellestial Health Comparables

Compare Cellestial Health with similar companies based on industry and business-model similarity.

Cellestial Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allyx Therapeutics, Inc.
77%
Astrocyte Pharmaceuticals Inc.
77%
NRG Therapeutics
73%

Cellestial Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 2, 2025
GrantSep 19, 2025
Pre SeedMay 8, 2025

Key People

Founding team and executive leadership

Nat Hastings

Chief Executive Officer

Executive Team

Cellestial Health Investors

Notable investors and investment history

Cellestial Health investors
InvestorRounds
ZincPre Seed
Parkinson's UKGrant
Alma AngelsPre Seed
Cambridge EnterpriseGrant
SFC CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors increased 72% MoM.

  • May 8, 2025

    $654K raised in Pre Seed round.

Cellestial Health Filings

Explore SEC and related filing metadata, where available.

Cellestial Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellestial Health's valuation, stock price, and market status.

Is Cellestial Health a public or private company?

Cellestial Health is a private company.

What is the current stock price of Cellestial Health?

Cellestial Health is a private company with no public stock price. No recent secondary market data is available.

How much is Cellestial Health worth (valuation)?

Valuation information for Cellestial Health is not publicly available.

Can I buy Cellestial Health stock?

Cellestial Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellestial Health's last funding round?

Cellestial Health's most recent funding round was Seed on December 2, 2025.

Who are the main investors in Cellestial Health?

Key investors in Cellestial Health include Zinc.

Will Cellestial Health IPO soon?

No public IPO plans have been announced for Cellestial Health.

How can I track Cellestial Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellestial Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range4
Year Founded2023
Last FundingDec 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?